Clinical Trial Update: An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD [EARLY_Phase 1]

View source ↗

Summary

FerruMax's exploratory Phase 1 trial of FMX-8 for anemia in chronic kidney disease has been terminated. The update notes the study status as TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in Chronic Kidney Disease

Drugs mentioned

• FMX-8

Snippet

Sponsor: FerruMax Pharmaceuticals, Inc. | Conditions: Anemia in Chronic Kidney Disease | EARLY_Phase 1 | Status: TERMINATED